Figure 1From: Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomesKaplan-Meier biochemical disease-free survival curve after SBRT for prostate cancer. Median follow-up is 5-years. Three of the 41 patients recurred, at 33, 37 and 42 months post-treatment. Tick marks indicate censored patients.Back to article page